Beacon Pointe Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-29,157
| Closed | -$408K | – | 995 |
|
|
2022
Q2 | $408K | Sell |
29,157
-6,200
| -18% | -$86.8K | 0.01% | 716 |
|
|
2022
Q1 | $856K | Buy |
35,357
+9,200
| +35% | +$223K | 0.01% | 667 |
|
|
2021
Q4 | $611K | Sell |
26,157
-15,298
| -37% | -$357K | 0.02% | 500 |
|
|
2021
Q3 | $689K | Sell |
41,455
-9,150
| -18% | -$152K | 0.02% | 471 |
|
|
2021
Q2 | $1.23M | Buy |
+50,605
| New | +$1.23M | 0.04% | 301 |
|